← brief for 2026-10-03 · People & money

Health technology assessment of long-acting erythropoiesis-stimulating agents for the treatment of renal anemia in China

Article No results yet Peer reviewed

Key takeaways

This study evaluates drugs that treat low blood counts in people with kidney disease. It looks at how these drugs are used in China. This is an assessment of drug use, not a clinical trial with new results.

Who did this work

Xinwen Wang (Nanjing Medical University) · Huiling Li (Nanjing Medical University) · Yazhuo Zhang (Nanjing Medical University) · Yinyin Duan (Nanjing Medical University)

Source

Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-10-02
https://doi.org/10.3389/fphar.2026.1878826